The Trueman flow: why timing is everything in biosimilars

Charlotte Kilpatrick

August 27 2020

Show more sharing options

Neil Trueman, chief international IP counsel at Mundipharma and corporate IP Star, delves into the IP challenges of biosimilar and generics manufacturing

Unlock this content.

The content you are trying to view is exclusive to our subscribers.

To unlock this content:

Take a Free Trial or Login

Topics

Charlotte Kilpatrick

Reporter Managing IP

Charlotte reports on patent-related issues. She often covers the European market, focusing on developments including FRAND, licensing and trade secrets. She is particularly interested in how new technologies affect IP challenges in the pharmaceutical industry.

more from across site and SHARED ros bottom lb

More from across our site

Patents

How Fenwick’s unblinking approach secured landmark ITC victory for Lashify

Saina Shamilov explains how she convinced the Federal Circuit to upend the US ITC’s domestic industry analysis

Rani Mehta, March 07 2025

Patents

Pierson Ferdinand seeks to double patent attorney headcount

Christopher Kinkade and Naira Simmons reveal the distributed firm’s hiring hopes for 2025, a little more than a year after it was founded

Rani Mehta, March 07 2025

Patents

This week on MIP: Trump targets Perkins Coie |Moderna's German win

A CJEU copyright decision on employees' rights and an update on an IP feud concerning foreign rights over 'Superman' were also among the top talking points

Sukanya Sarkar, March 07 2025

Patents

Sand running through the bulbs of an hourglass measuring the pas

Firms plan earlier petitions in wake of PTAB policy shift

Counsel explain how firms advising PTAB petitioners may react to the USPTO’s decision to ditch Fintiv guidance

Rani Mehta, March 07 2025

Patents

Search new job, finding candidate or discover talent, hiring and recruitment, SEO search engine optimization, find career opportunity concept, business people HR push magnifying glass on search, Gener

Exclusive: HGF hires four as post-PE investment ramps up

The recruits include another former Stobbs lawyer, as well as a chief technology officer and chief financial officer

Max Walters, March 07 2025

Patents

goldfish jumping - improvement and career concept

IP litigator impressed by trial-readiness at Cole Schotz

Jeffrey Saltman, who is anticipating a continued ‘ramping up’ of 5G patent litigation, has joined Cole Schotz

Rani Mehta, March 06 2025

The IP Lounge: Managing IP EMEA Awards 2025 preview

We look ahead to next month’s EMEA Awards, discussing the recently published shortlists, our research methodology and what makes the Awards special

Max Walters, March 06 2025

Patents

OC and Gowling on winning side in Tesla-Avanci FRAND row

EIP also emerged victorious as the England and Wales Court of Appeal backed a challenge brought by Avanci and InterDigital against the electric carmaker

Max Walters, March 06 2025

Patents

Why new FB Rice leader is betting on IP advisory

Madeleine Kelly, the Australia-based IP firm’s new managing partner, discusses its new advisory offering, a promising fresh hire and changing market dynamics

Sukanya Sarkar, March 06 2025

Conceptual digital art highlighting the deepfake technology phenomenon.

Weekly take: Why deepfakes pose a threat to women’s IP rights

Ahead of International Women’s Day, Véronique Dahan argues why a coordinated approach must be implemented to protect women from malicious use of AI

Véronique Dahan, March 06 2025